Purchases and Sales Made in Q2 2022 in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during Q2 2022. The information is specifically focused on institutions that hold shares of EAGLE PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-28.2K- 14.57% |
$1.17M - $1.45M
|
166K
$99.3K
|
|
|
Aug 15, 2022
Q2 2022
|
Man Group PLC
London, X0 |
SELL
|
- |
-31.3K- 22.49% |
$1.29M - $1.61M
|
108K
$64.8K
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-33.9K- 14.2% |
$1.4M - $1.74M
|
205K
$123K
|
|
|
Aug 12, 2022
Q2 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-41K- 97.39% |
$1.69M - $2.1M
|
1.1K
$659
|
|
|
Jul 25, 2022
Q2 2022
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-43.8K- 17.39% |
$1.81M - $2.25M
|
208K
$125K
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-45K- 2.27% |
$1.86M - $2.31M
|
1.94M
$1.16M
|
|
|
Aug 15, 2022
Q2 2022
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-48K- 40.31% |
$1.98M - $2.47M
|
71.1K
$42.7K
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-48.1K- 3.24% |
$1.98M - $2.47M
|
1.44M
$862K
|
|
|
Aug 15, 2022
Q2 2022
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-69.1K- 71.31% |
$2.85M - $3.55M
|
27.8K
$16.7K
|
|
|
Aug 11, 2022
Q2 2022
|
South Dakota Investment Council
Sioux Falls, SD |
SELL
|
- |
-70.1K- 76.54% |
$2.89M - $3.6M
|
21.5K
$12.9K
|
|
|
Aug 15, 2022
Q2 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-74K- 33.04% |
$3.05M - $3.8M
|
150K
$90K
|